ARCHIVES

In Brief: Doug Ulman named CEO of Pelotonia

This article is from The Cancer Letter archive.

Vol. 40 No. 36 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

February 4, 2005

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995